Literature DB >> 27340630

Preventive Audiology: Screening for Hearing Impairment in Children Having Recurrent URTI.

K Sharma1, M S Pannu2, A Arora1, V Sharma1.   

Abstract

A late detection of hearing impairment in children can affect speech and language development. Otitis media with effusion (OME) associated with risk factors like recurrent upper respiratory tract infections (URTI) is considered the most common cause of silent hearing impairment among children. So this study was carried out to screen such at risk children for hearing impairment. The study was conducted on 1000 children in the age group of 2-12 years who presented to the OPD of ENT and Pediatrics Department, Govt Medical College with the complaint of recurrent URTI. The children were screened by history taking, general physical examination and local ENT examination. This was followed by impedance audiometry and pure tone audiometry (PTA, wherever indicated). Children with discharging ears and perforated tympanic membrane (TM) were excluded from the study. The most common presenting complaint was nasal discharge (67.9 %), followed by mouth breathing (66.3 %) and snoring (65 %). Only 16.2 % cases actually complained of some hearing impairment on exploratory history indicating the silent nature of OME. On examination 52.65 % cases had a normal looking TM whereas 41.2 % had a dull retracted TM. Results of impedance audiometry showed Type A graph in 56.75 %, Type B in 33.4 % indicating OME and Type C in 9.85 % indicating Eustachian tube dysfunction. PTA showed a mild conductive hearing loss in 26.7 % cases. OME is quite prevalent in high risk children and incidence of OME resulting in silent hearing impairment is quite high especially in young children having recurrent URTI. Impedance audiometry has been proved to be an objective screening tool for the same with a diagnostic accuracy of 87 % and thus under preventive audiology, it has a definite role in young children having recurrent URTI.

Entities:  

Keywords:  Impedance; OME; Recurrent URC

Year:  2015        PMID: 27340630      PMCID: PMC4899367          DOI: 10.1007/s12070-015-0937-1

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  9 in total

Review 1.  The impact of early identification of permanent childhood hearing impairment on speech and language outcomes.

Authors:  Hannah Pimperton; Colin R Kennedy
Journal:  Arch Dis Child       Date:  2012-05-01       Impact factor: 3.791

2.  Adenoidectomy for middle ear effusion: a study of 50,000 children over 24 years.

Authors:  Abdul Latif Kadhim; Katrina Spilsbury; James B Semmens; Harvey L Coates; Francis J Lannigan
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

3.  The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction.

Authors:  W T McNicholas
Journal:  Eur Respir J       Date:  2008-07       Impact factor: 16.671

Review 4.  Tympanometry. ASHA Working Group on Aural Acoustic-Immittance Measurements Committee on Audiologic Evaluation.

Authors: 
Journal:  J Speech Hear Disord       Date:  1988-11

5.  Secretory otitis media: A school health survey.

Authors:  S P S Yadav; Sanjay Saxena; Harshini Sharma; Ishwer Singh; Jagat Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-07

6.  The epidemiology of childhood hearing impairment: factor relevant to planning of services.

Authors:  A Davis; S Wood
Journal:  Br J Audiol       Date:  1992-04

7.  Incidence of uncomplained secretory otitis media in patients undergoing adenotonswlectomy.

Authors:  Vikas Sinha; Bhavin H Patel; Sudipti Sinha
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-04

8.  Middle ear and hearing disorders of schoolchildren aged 7-10 years in South Sinai, Egypt.

Authors:  G Yamamah; A Mabrouk; E Ghorab; M Ahmady; H Abdulsalam
Journal:  East Mediterr Health J       Date:  2012-03       Impact factor: 1.628

9.  Newborn hearing screening: present scenario.

Authors:  Vishwambhar Singh
Journal:  Indian J Community Med       Date:  2015 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.